Align Technology | ALGN - Current Liabilities

Stock Price
162.81
Daily Change
-0.22 -0.13%
Monthly
1.67%
Yearly
-24.56%
Q1 Forecast
158.01

Align Technology reported $1.97B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
3M USD 9.6B 862M Dec/2025
Align Technology USD 1.97B 29.02M Sep/2025
Becton, Dickinson and Co. USD 8.31B 153M Sep/2025
Bruker USD 1.27B 79.3M Sep/2025
Cardinal Health USD 40.27B 1.37B Sep/2025
Charles River Laboratories USD 1.12B 41.45M Sep/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
CVS Health USD 92.7B 1.47B Sep/2025
Danaher USD 6.81B 483M Dec/2025
Dentsply International USD 1.4B 239M Sep/2025
Dexcom USD 3.34B 27.3M Sep/2025
Henry Schein USD 3.15B 142M Sep/2025
Idexx Laboratories USD 1.25B 27.93M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
IQVIA Holdings USD 8.51B 936M Sep/2025
Masimo USD 369.7M 222.4M Sep/2025
McKesson USD 68.03B 3.7B Sep/2025
Mettler Toledo International USD 1.19B 85.24M Sep/2025
Revvity USD 1.22B 550.93M Sep/2025
Solventum Corp USD 2.94B 318M Sep/2025
Stryker USD 7.79B 380M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Veeva Systems USD 944.88M 310.18M Sep/2025
Waters USD 1.25B 235.17M Sep/2025
Zimmer Biomet Holdings USD 2.4B 296.6M Sep/2025
Zoetis USD 1.81B 1.56B Sep/2025